Psychemedics Corporation
PMDI
$2.30
$0.062.68%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -14.49% | 9.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.49% | 9.45% | |||
| Cost of Revenue | -3.16% | -1.26% | |||
| Gross Profit | -31.93% | 31.38% | |||
| SG&A Expenses | -57.72% | 8.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.22% | 2.54% | |||
| Operating Income | 128.24% | 33.82% | |||
| Income Before Tax | 126.40% | 32.52% | |||
| Income Tax Expenses | 59.15% | 0.00% | |||
| Earnings from Continuing Operations | 135.33% | 35.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 135.33% | 35.31% | |||
| EBIT | 128.24% | 33.82% | |||
| EBITDA | 188.41% | 49.24% | |||
| EPS Basic | 134.80% | 36.15% | |||
| Normalized Basic EPS | 125.97% | 33.37% | |||
| EPS Diluted | 131.72% | 36.15% | |||
| Normalized Diluted EPS | 125.97% | 33.37% | |||
| Average Basic Shares Outstanding | 1.58% | 1.32% | |||
| Average Diluted Shares Outstanding | 1.58% | 1.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||